ELDN · Eledon Pharmaceuticals, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“management has concluded that substantial doubt exists about our ability to continue as a going concern. Although management intends to obtain additional financing through the sources described above, these plans are subject to market conditions and other factors outside our control. Accordingly, management has concluded that its plans do not alleviate the substantial doubt about our ability to continue as a going concern.”